📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Epitomics

1.1 - Company Overview

Epitomics Logo

Epitomics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of monoclonal antibody technology and life science research tools, developing proprietary RabMAb® (Rabbit Monoclonal Antibody) antibodies with superior binding affinity, specificity, and bioactivity for research and diagnostic applications. Offerings include primary and secondary antibodies, recombinant options, antibody panels, proteins, and kits and reagents including ELISA kits.

Products and services

  • Antibodies: In vivo-grade antibodies validated for commercial use, offered for research and diagnostic applications, including a chimera with a mouse IgG2c backbone for specific in vivo use
  • Kits and Reagents: Assay-grade kits and reagents essential for life science research, including ELISA kits and other assay tools for experimental detection and quantification workflows
  • Primary Antibodies: Research-grade primary antibodies leveraging proprietary RabMAb rabbit monoclonal technology deliver superior binding affinity, specificity, and bioactivity to detect and quantify antigens, including monoclonal, polyclonal, and recombinant monoclonal options

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Epitomics

Culture Biosciences Logo

Culture Biosciences

HQ: United States Website
  • Description: Provider of cloud-connected bioreactors and Console software enabling remote, real-time design, monitoring, and analysis of cell culture and bioprocess experiments, plus bioprocess development services including clone screening, process characterization, media screening, and process optimization.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Culture Biosciences company profile →
Emulate Logo

Emulate

HQ: United States Website
  • Description: Provider of advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Emulate company profile →
Taconic Biosciences Logo

Taconic Biosciences

HQ: United States Website
  • Description: Provider of animal models and related laboratory services for biomedical research, offering over 4,500 genetically engineered mouse and rat models, including repository models, standard strains, GEMs, and humanized immune system models. Services include custom model generation, colony management, FcResolv NOG-EXL superimmunodeficient mice, and the Wild Mouse Microbiome toolkit for drug discovery.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Taconic Biosciences company profile →
Atera Labs Logo

Atera Labs

HQ: Luxembourg Website
  • Description: Provider of advanced human tissue models and tissue engineering solutions, specializing in R&D, validation, manufacturing and commercialization to deliver reliable, cost-effective, high-quality test methods for product evaluation, gradually reducing and replacing animal experimentation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Atera Labs company profile →
Q Chip Logo

Q Chip

HQ: United Kingdom Website
  • Description: Provider of biopharmaceutical drug delivery, developing a range of sustained-release biogeneric and biotherapies products (Q-Sphera).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Q Chip company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Epitomics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Epitomics

2.2 - Growth funds investing in similar companies to Epitomics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Epitomics

4.2 - Public trading comparable groups for Epitomics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Epitomics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Epitomics

What does Epitomics do?

Epitomics is a provider of monoclonal antibody technology and life science research tools, developing proprietary RabMAb® (Rabbit Monoclonal Antibody) antibodies with superior binding affinity, specificity, and bioactivity for research and diagnostic applications. Offerings include primary and secondary antibodies, recombinant options, antibody panels, proteins, and kits and reagents including ELISA kits.

Who are Epitomics's competitors?

Epitomics's competitors and similar companies include Culture Biosciences, Emulate, Taconic Biosciences, Atera Labs, and Q Chip.

Where is Epitomics headquartered?

Epitomics is headquartered in United States.

How many employees does Epitomics have?

Epitomics has 1,000 employees 🔒.

When was Epitomics founded?

Epitomics was founded in 2010 🔒.

What sector and industry vertical is Epitomics in?

Epitomics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Epitomics

Who are the top strategic acquirers in Epitomics's sector and industry

Top strategic M&A buyers and acquirers in Epitomics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Epitomics?

Top strategic M&A buyers groups and sectors for Epitomics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Epitomics's sector and industry vertical

Which are the top PE firms investing in Epitomics's sector and industry vertical?

Top PE firms investing in Epitomics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Epitomics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Epitomics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Epitomics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Epitomics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Epitomics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Epitomics?

The key public trading comparables and valuation benchmarks for Epitomics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Epitomics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Epitomics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Epitomics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Epitomics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Epitomics's' sector and industry vertical?

Access recent funding rounds and capital raises in Epitomics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Epitomics

Launch login modal Launch register modal